Analyst Price Targets — PRTA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 24, 2026 11:28 am | Andrew Fein | H.C. Wainwright | $30.00 | $8.53 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Prothena Corp (PRTA) |
| March 13, 2026 10:30 am | — | Stifel Nicolaus | $19.00 | $9.31 | StreetInsider | Prothena (PRTA) Reiterated at Market Outperform by Citizens After Fireside Chat |
| December 1, 2025 10:38 am | Jason Butler | JMP Securities | $19.00 | $10.75 | TheFly | Prothena price target raised to $19 from $11 at Citizens JMP |
| December 1, 2025 9:32 am | — | Deutsche Bank | $19.00 | $10.75 | StreetInsider | Prothena Corp (PRTA) PT Raised to $19 at Citizens: Discovery Engine Successful |
| October 28, 2025 12:14 pm | Yasmeen Rahimi | Piper Sandler | $36.00 | $11.09 | StreetInsider | Prothena Corp (PRTA) PT Raised to $36 as Piper Sandler Remains Bullish |
| October 28, 2025 10:38 am | — | UBS | $36.00 | $11.31 | TheFly | Prothena price target raised to $36 from $15 at Piper Sandler |
| October 7, 2025 12:32 pm | — | H.C. Wainwright | $20.00 | $9.86 | TheFly | Prothena price target raised to $20 from $14 at H.C. Wainwright |
| September 2, 2025 10:36 am | Jason Butler | JMP Securities | $11.00 | $8.27 | TheFly | Prothena price target lowered to $11 from $29 at Citizens JMP |
| August 14, 2024 7:40 am | Jay Olson | Oppenheimer | $62.00 | $19.77 | StreetInsider | Prothena Corp (PRTA) PT Lowered to $62 at Oppenheimer |
| August 9, 2024 6:27 am | Kennen MacKay | RBC Capital | $24.00 | $19.68 | StreetInsider | Prothena Corp (PRTA) PT Lowered to $24 at RBC Capital |
Latest News for PRTA
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Prothena (PRTA). But which of these two companies is the best option for those looking for undervalued stocks?
Prothena beat adjusted Q2 loss estimates, reaffirmed 2026 cash-use guidance and highlights partner pipeline progress as a key milestone decision nears.
Prothena (PRTA) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $1.86 per share a year ago.
DUBLIN--(BUSINESS WIRE)---- $PRTA #Prothena--Prothena reported financial results for the second quarter and first six months of 2026 and provided business highlights.
Shares of Prothena Corporation plc (NASDAQ: PRTA - Get Free Report) passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $9.46 and traded as low as $8.51. Prothena shares last traded at $8.75, with a volume of 647,643 shares trading hands. Wall Street Analyst Weigh In
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PRTA.
U.S. House Trading
No House trades found for PRTA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.